Back to Search
THOMAS HUGHES, MD
MD
Specialist
NPI: 1831379213IndividualAccepts Medicare
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
19697(SC)
CMS Specialties
PrimaryNEUROLOGY
Education
MEDICAL UNIVERSITY OF SOUTH CAROLINA COLLEGE OF MEDICINE
Class of 1992
Research & Publications (20)
Clinical strategies to achieve an early and successful response to tyrosine kinase inhibitor therapy.
PMID 19621544·Semin Hematol·2009
8-other
Impact of baseline BCR-ABL mutations on response to nilotinib in patients with chronic myeloid leukemia in chronic phase.
PMID 19652056·J Clin Oncol·2009
3-trial
Identification of the high affinity binding site in the Streptococcus intermedius toxin intermedilysin for its membrane receptor, the human complement regulator CD59.
PMID 19200600·Mol Immunol·2009
7-preclinical
Real-time PCR assays for the quantification of Phialophora gregata f. sp. sojae IGS genotypes A and B.
PMID 19671002·Phytopathology·2009
8-other
Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy.
PMID 18768781·Blood·2008
3-trial
First records of Aedes japonicus japonicus in Wisconsin.
PMID 19181068·J Am Mosq Control Assoc·2008
7-preclinical
The association between social resources and cognitive change in older adults: evidence from the Charlotte County Healthy Aging Study.
PMID 18689766·J Gerontol B Psychol Sci Soc Sci·2008
8-other
Is drug treatment superior to allografting as first-line therapy in chronic myeloid leukemia?
PMID 17940526·Nat Clin Pract Oncol·2008
8-other
Evaluating dosage compensation as a cause of duplicate gene retention in Paramecium tetraurelia.
PMID 17521457·Genome Biol·2007
6-review
Strong genetic control of emergence of human primary incisors.
PMID 18037648·J Dent Res·2007
4-observational
Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results.
PMID 16522812·Blood·2006
6-review
ABL kinase inhibitor therapy for CML: baseline assessments and response monitoring.
PMID 17124063·Hematology Am Soc Hematol Educ Program·2006
6-review
Underestimation of mortality due to chronic obstructive pulmonary disease (COPD) in Kentucky.
PMID 16939035·J Ky Med Assoc·2006
4-observational
Regions of alpha-amino-5-methyl-3-hydroxy-4-isoxazole propionic acid receptor subunits that are permissive for the insertion of green fluorescent protein.
PMID 16765522·Neuroscience·2006
4-observational
Molecular monitoring of BCR-ABL as a guide to clinical management in chronic myeloid leukaemia.
PMID 16426942·Blood Rev·2006
6-review
Combining beta-adrenergic and peroxisome proliferator-activated receptor gamma stimulation improves lipoprotein composition in healthy moderately obese subjects.
PMID 16324916·Metabolism·2006
2-rct
New paradigms for supporting the resilience of marine ecosystems.
PMID 16701400·Trends Ecol Evol·2005
8-other
Visualising very large phylogenetic trees in three dimensional hyperbolic space.
PMID 15117420·BMC Bioinformatics·2004
7-preclinical
Mortality in Parkinson's disease and its association with dementia and depression.
PMID 15242420·Acta Neurol Scand·2004
8-other
Reducing unintended pregnancy in young, single active duty women in an overseas environment.
PMID 12546238·Mil Med·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 913 B BOWMAN RD
MT. PLEASANT, SC 29464 - Phone
- (843) 856-9530
Quick Facts
- NPI
- 1831379213
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 34
- Publications
- 20
Are you this provider?
Claim Your Profile